These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16513737)

  • 1. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo.
    Loutet SA; Flannagan RS; Kooi C; Sokol PA; Valvano MA
    J Bacteriol; 2006 Mar; 188(6):2073-80. PubMed ID: 16513737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.
    Ortega X; Hunt TA; Loutet S; Vinion-Dubiel AD; Datta A; Choudhury B; Goldberg JB; Carlson R; Valvano MA
    J Bacteriol; 2005 Feb; 187(4):1324-33. PubMed ID: 15687196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin B.
    Ortega X; Silipo A; Saldías MS; Bates CC; Molinaro A; Valvano MA
    J Biol Chem; 2009 Aug; 284(32):21738-51. PubMed ID: 19525227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoarabinose is essential for lipopolysaccharide export and intrinsic antimicrobial peptide resistance in Burkholderia cenocepacia(†).
    Hamad MA; Di Lorenzo F; Molinaro A; Valvano MA
    Mol Microbiol; 2012 Sep; 85(5):962-74. PubMed ID: 22742453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes.
    Loutet SA; Di Lorenzo F; Clarke C; Molinaro A; Valvano MA
    BMC Genomics; 2011 Sep; 12():472. PubMed ID: 21955326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.
    Loutet SA; Valvano MA
    Front Cell Infect Microbiol; 2011; 1():6. PubMed ID: 22919572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo.
    Flannagan RS; Aubert D; Kooi C; Sokol PA; Valvano MA
    Infect Immun; 2007 Apr; 75(4):1679-89. PubMed ID: 17220310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suhB gene of Burkholderia cenocepacia is required for protein secretion, biofilm formation, motility and polymyxin B resistance.
    Rosales-Reyes R; Saldías MS; Aubert DF; El-Halfawy OM; Valvano MA
    Microbiology (Reading); 2012 Sep; 158(Pt 9):2315-2324. PubMed ID: 22767545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia.
    Bernier SP; Sokol PA
    J Bacteriol; 2005 Aug; 187(15):5278-91. PubMed ID: 16030222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.
    Urban TA; Griffith A; Torok AM; Smolkin ME; Burns JL; Goldberg JB
    Infect Immun; 2004 Sep; 72(9):5126-34. PubMed ID: 15322006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-tier model of polymyxin B resistance in Burkholderia cenocepacia.
    Loutet SA; Mussen LE; Flannagan RS; Valvano MA
    Environ Microbiol Rep; 2011 Apr; 3(2):278-85. PubMed ID: 23761261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkholderia cenocepacia strains isolated from cystic fibrosis patients are apparently more invasive and more virulent than rhizosphere strains.
    Pirone L; Bragonzi A; Farcomeni A; Paroni M; Auriche C; Conese M; Chiarini L; Dalmastri C; Bevivino A; Ascenzioni F
    Environ Microbiol; 2008 Oct; 10(10):2773-84. PubMed ID: 18643926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
    Mil-Homens D; Bernardes N; Fialho AM
    FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of the lipopolysaccharide deacylase PagL from latency compensates for a lack of lipopolysaccharide aminoarabinose modification-dependent resistance to the antimicrobial peptide polymyxin B in Salmonella enterica.
    Kawasaki K; China K; Nishijima M
    J Bacteriol; 2007 Jul; 189(13):4911-9. PubMed ID: 17483225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Broad-Host-Range Tailocin from Burkholderia cenocepacia.
    Yao GW; Duarte I; Le TT; Carmody L; LiPuma JJ; Young R; Gonzalez CF
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections.
    Sokol PA; Sajjan U; Visser MB; Gingues S; Forstner J; Kooi C
    Microbiology (Reading); 2003 Dec; 149(Pt 12):3649-3658. PubMed ID: 14663096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental Burkholderia cenocepacia Strain Enhances Fitness by Serial Passages during Long-Term Chronic Airways Infection in Mice.
    Bragonzi A; Paroni M; Pirone L; Coladarci I; Ascenzioni F; Bevivino A
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29135920
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.
    Bazzini S; Udine C; Riccardi G
    Appl Microbiol Biotechnol; 2011 Dec; 92(5):887-95. PubMed ID: 21997606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315).
    Silipo A; Molinaro A; Ieranò T; De Soyza A; Sturiale L; Garozzo D; Aldridge C; Corris PA; Khan CM; Lanzetta R; Parrilli M
    Chemistry; 2007; 13(12):3501-11. PubMed ID: 17219455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia.
    Loutet SA; El-Halfawy OM; Jassem AN; López JM; Medarde AF; Speert DP; Davies JE; Valvano MA
    Int J Antimicrob Agents; 2015 Oct; 46(4):376-80. PubMed ID: 26187366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.